Research brief
New research from the Academy of Military Medical Sciences in Beijing has uncovered a rather intriguing finding: natural melanin nanozymes (NMNs) derived from octopus ink may potentially slow ageing, protect against neurodegenerative diseases, and extend lifespan. Published in ACS Omega, the study reveals how these nanozymes work at the cellular level to mitigate oxidative stress, improve gut health, and enhance brain function, offering a new frontier in anti-ageing and neurological research.
What are Melanin Nanozymes?
Melanin, best known as the pigment responsible for skin and hair colour, has also been recognized for its potent antioxidant properties. Nanozymes created from natural melanin, like those extracted from octopus ink, mimic the activity of antioxidant enzymes such as superoxide dismutase (SOD). These nanozymes neutralize free radicals, reduce oxidative stress, and improve cellular health—processes that are critical in mitigating ageing and the onset of neurodegenerative diseases.
Key Findings from the Study
The research team administered NMNs to senescence-accelerated mice (SAMP8), a widely used model for studying ageing and neurodegenerative disorders. The findings were highly promising:
1. Lifespan Extension:
NMN-treated mice showed a significant increase in lifespan compared to untreated mice. By slowing the cellular processes that contribute to ageing, NMNs helped extend the active and healthy lives of the mice.
2. Cognitive Improvement:
Behavioural tests, including the Morris water maze, demonstrated that NMNs improved memory and learning capabilities in ageing mice. This improvement in cognitive function correlates with reduced oxidative damage and inflammation in the brain.
3. Gut Microbiota Restoration:
One of the most surprising results was the effect of NMNs on gut health. The treatment enhanced gut microbial diversity and restored the balance of beneficial bacteria, reinforcing the critical role of the gut-brain axis in ageing and neurodegeneration.
4. Oxidative Stress Reduction:
NMNs significantly decreased malondialdehyde (MDA) levels in the brain—a key marker of oxidative stress. By protecting neurons from oxidative damage, NMNs directly mitigated one of the primary drivers of neurodegeneration.
The Gut-Brain Connection
A particularly noteworthy aspect of the study is the impact of NMNs on the gut-brain axis. Ageing and neurodegenerative diseases are increasingly linked to disruptions in gut microbiota, which can influence immune function, inflammation, and even cognition. By rebalancing the gut microbiota, NMNs indirectly promote a healthier brain environment, adding a novel layer to their therapeutic potential.
Dr. Xiao, lead author of the study, emphasized this point: “Our findings suggest that the benefits of NMNs extend beyond direct antioxidant activity. By restoring gut microbial diversity, these nanozymes support systemic health, potentially delaying both cognitive decline and physical aging.”
Implications for Neurodegenerative Diseases
The findings have significant implications for the treatment of neurodegenerative disorders such as Alzheimer’s and Parkinson’s diseases. Both conditions are characterized by oxidative stress, chronic inflammation, and disruptions in cellular homeostasis—areas where NMNs demonstrated clear benefits in preclinical models.
By targeting both the brain and gut, NMNs offer a dual-action approach to addressing neurodegeneration. For Alzheimer’s, NMNs could potentially reduce amyloid-beta plaque formation and neuroinflammation. For Parkinson’s, they may mitigate oxidative stress in dopaminergic neurons, slowing disease progression.
Challenges and Future Directions
While the results are promising, further research is necessary to translate these findings into clinical applications. Key challenges include scaling up the production of NMNs, ensuring their safety in long-term human studies, and optimizing delivery methods to maximize their bioavailability. Additionally, understanding the precise molecular mechanisms by which NMNs interact with gut microbiota and brain cells will be critical for developing targeted therapies.
The potential for NMNs goes beyond treating neurodegenerative diseases. As ageing is a major risk factor for numerous conditions, these natural nanozymes could play a role in addressing cardiovascular disease, diabetes, and other age-related disorders.
A New Era of Natural Therapeutics
The discovery of NMNs from octopus ink represents an exciting intersection of marine biology and medicine. With their ability to enhance lifespan, improve brain function, and restore gut health, NMNs could redefine how we approach ageing and age-related diseases.
This study underscores the importance of looking to nature for innovative solutions to complex medical challenges. As researchers delve deeper into the potential of NMNs, they may unlock new ways to combat ageing and protect against the growing global burden of neurodegenerative diseases.
For now, the humble octopus ink—a natural substance with extraordinary properties—might hold the key to extending both the length and quality of human life.
Discover more from Neurospan
Subscribe to get the latest posts sent to your email.


